AlphaYouSB
Schedule 13G filing
Samsara BioCapital, L.P. disclosed a 9.9% stake in PMV Pharmaceuticals, Inc. (PMVP)
Samsara BioCapital, L.P. reported owning 9.9% of PMV Pharmaceuticals, Inc. (PMVP) (7,577,467 shares) in a Schedule 13G filed Sep 15, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Sep 15, 2026
- Source
- Schedule 13G
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.